This site is intended for health professionals only

Published on 20 March 2008

Share this story:

RELATED ARTICLES
Molecule effective against organism causing nosocomial infections identified via machine learning
Malarial monoclonal antibody highly effective at 6 months
Commonly used sepsis model fails to identify over two-thirds of patients with the condition
Using a mobile app to trace close proximity coronavirus contacts
Worse outcomes for COVID-19 patients with CV disease

Health economics of treating multidrug-resistant Gram-positive infections: a qualitative critique

teaser

This review considers analyses undertaken on the economic impact of healthcare-acquired infections and the pharmacoeconomic impact of new drug therapies, including antibiotics such as linezolid

Dilip Nathwani
MB FRCP DTM&H

Consultant Physician and Honorary Professor

Infection Unit
Ninewells Hospital and Medical School
Dundee
UK

SENTRY antimicrobial programme data for 1997



Most read

1
Oral vitamin A could become an alternative to isotretinoin for acne
2
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
5
Launch of the new Hospital Pharmacy Europe Mobile App



Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
Share this story:

RELATED ARTICLES
Home-based HF program
Adalimumab helps treat AS
Advancing medication management into the future
Positive opinion for abiraterone acetate to include earlier stage prostate cancer patients
Embattled Astra sees profits fall
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2024
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x